A study has demonstrated that transplanting human embryonic stem cell–derived, insulin-producing cells shielded in capsules made with an optimized biomaterial can achieve long-term cure of diabetes in mice without the need for any immunosuppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Marina Corral Spence/Nature Publishing Group
References
Vegas, A.J. et al. Nat. Med. 22, 306–311 (2016).
Vegas, A.J. et al. Nat. Biotechnol. 34, 306–311 (2016).
Naujok, O., Burns, C., Jones, P.M. & Lenzen, S. Mol. Ther. 19, 1759–1768 (2011).
D'Amour, K.A. et al. Nat. Biotechnol. 24, 1392–1401 (2006).
Pagliuca, F.W. et al. Cell 159, 428–439 (2014).
Russ, H.A. et al. EMBO J. 34, 1759–1772 (2015).
Rezania, A. et al. Nat. Biotechnol. 32, 1121–1133 (2014).
Scharp, D.W. & Marchetti, P. Adv. Drug Deliv. Rev. 67–68, 35–73 (2014).
Khosravi-Maharlooei, M. et al. Eur. J. Endocrinol. 173, R165–R183 (2015).
Bratlie, K.M. et al. PLoS One 5, e10032 (2010).
Andersson Trojer, M., Movahedi, A., Blanck, H. & Nydén, M. J. Chem. 2013, 946739 (2013).
Jacobs-Tulleneers-Thevissen, D. et al. Diabetologia 56, 1605–1614 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tang, Q., Desai, T. Approaching a cure for type 1 diabetes. Nat Med 22, 236–237 (2016). https://doi.org/10.1038/nm.4060
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4060
